Maximilian A R Strobl

Cituota

	Visi	Nuo 2020
Šaltiniai	484	470
h-rodyklė	12	12
i10-rodyklė	14	14

200

100

150

20162017201820192020202120222023202420252 2 4 4 25 46 48 134 186 30

Viešas pasiekiamumas

Peržiūrėti viską

16 straipsnių

0 straipsnių

pasiekiami

nepasiekiami

Pagal finansavimo įpareigojimus

Bendraautoriai

Alexander R. A. AndersonChair of Integrated Mathematical Oncology, Moffitt Cancer CenterPatvirtintas el. paštas moffitt.org
Mark Robertson-TessiIntegrated Mathematical Oncology, Moffitt Cancer CenterPatvirtintas el. paštas moffitt.org
Jeffrey WestIntegrated Mathematical Oncology, Moffitt Cancer CenterPatvirtintas el. paštas moffitt.org
Philip MainiProfessor of Mathematical BiologyPatvirtintas el. paštas maths.ox.ac.uk
Mehdi DamaghiAssistant professor at Stony Brook medicine, dept of pathology and SB cancer centerPatvirtintas el. paštas stonybrookmedicine.edu
Joel S BrownMoffitt Cancer CenterPatvirtintas el. paštas darwiniandynamics.org
Robert GilliesChair of Cancer Physiology, H. Lee Moffitt Cancer CenterPatvirtintas el. paštas moffitt.org
Andriy MarusykMoffitt Cancer CenterPatvirtintas el. paštas moffitt.org
Andrew KrauseDurham UniversityPatvirtintas el. paštas durham.ac.uk
Liliana Ramona DemenescuDepartment of Psychiatry, Psychotherapy and Psychosomatic, Uniklinik Aachen, GermanyPatvirtintas el. paštas canlab.de
Maarten De VosESAT - Stadius & Department of Development and Regeneration, KU Leuven, BelgiumPatvirtintas el. paštas kuleuven.be
Michael LindemannBaden-Wuerttemberg Cooperative State UniversityPatvirtintas el. paštas dhbw-loerrach.de
Heiko EnderlingProfessor, Radiation Oncology, Inst. for Data Science, MD Anderson Cancer Center, Houston, TX, USAPatvirtintas el. paštas mdanderson.org
Lee Curtin, PhDSenior Bioinformatician, Precision Neurotherapeutics Innovation Program, Mayo ClinicPatvirtintas el. paštas mayo.edu
Daniel NicholEvolutionary Genomics and Modelling, Institute of Cancer Research, UKPatvirtintas el. paštas icr.ac.uk
Ilke TunaliEli Lilly & CompanyPatvirtintas el. paštas lilly.com
Jamie DeanJunior Group Leader, University College LondonPatvirtintas el. paštas ucl.ac.uk
Iman Tavassoly, MD, PhDVirginia Tech, Icahn School of Medicine at Mount SinaiPatvirtintas el. paštas vt.edu
Inmaculada C. SorribesQuantitative Pharmacology and Pharmacometrics Immune/Oncology, MerckPatvirtintas el. paštas merck.com
Jakob Nikolas Kather, MD, MScElse Kroener Fresenius Center for Digital Health, Technical University Dresden, Dresden, GermanyPatvirtintas el. paštas tu-dresden.de

Stebėti

Maximilian A R Strobl

Postdoctoral Research Fellow, Cleveland Clinic, USA

Patvirtintas el. paštas ccf.org - Pagrindinis puslapis

Mathematical Oncology Evolutionary Therapy Cancer Ecology and Evolution


Pavadinimas Rūšiuoti pagal šaltinius Rūšiuoti pagal metus Rūšiuoti pagal pavadinimą	Cituota Cituota	Metai
Turnover modulates the need for a cost of resistance in adaptive therapy MAR Strobl, J West, Y Viossat, M Damaghi, M Robertson-Tessi, JS Brown, ... Cancer research 81 (4), 1135-1147, 2021	118	2021
Spatial structure impacts adaptive therapy by shaping intra-tumoral competition MAR Strobl, J Gallaher, J West, M Robertson-Tessi, PK Maini, ... Communications Medicine 2 (1), 1-18, 2022	65	2022
A survey of open questions in adaptive therapy: Bridging mathematics and clinical translation J West, F Adler, J Gallaher, M Strobl, R Brady-Nicholls, J Brown, ... Elife 12, e84263, 2023	53	2023
Look me in the eye: evaluating the accuracy of smartphone-based eye tracking for potential application in autism spectrum disorder research MAR Strobl, F Lipsmeier, LR Demenescu, C Gossens, M Lindemann, ... Biomedical engineering online 18 (1), 1-12, 2019	42	2019
Immunosuppressive niche engineering at the onset of human colorectal cancer CD Gatenbee, AM Baker, RO Schenck, M Strobl, J West, MP Neves, ... Nature Communications 13 (1), 1-16, 2022	36	2022
Mix and Match: Phenotypic Coexistence as a Key Facilitator of Cancer Invasion MAR Strobl, AL Krause, M Damaghi, R Gillies, ARA Anderson, PK Maini Bulletin of Mathematical Biology 82 (1), 1-26, 2020	24	2020
On simulated annealing phase transitions in phylogeny reconstruction MAR Strobl, D Barker Molecular phylogenetics and evolution 101, 46-55, 2016	23	2016
Treatment of evolving cancers will require dynamic decision support MAR Strobl, J Gallaher, M Robertson-Tessi, J West, ARA Anderson Annals of Oncology 34 (10), 867-884, 2023	22	2023
Drug dependence in cancer is exploitable by optimally constructed treatment holidays J Maltas, ST Killarney, KR Singleton, MAR Strobl, R Washart, KC Wood, ... Nature Ecology & Evolution 8 (1), 147-162, 2024	19	2024
Mathematical Model-Driven Deep Learning Enables Personalized Adaptive Therapy K Gallagher, MAR Strobl, DS Park, FC Spoendlin, RA Gatenby, PK Maini, ... Cancer Research 84 (11), 1929-1941, 2024	13	2024
Inter-and intra-metastatic heterogeneity shapes adaptive therapy cycling dynamics J Gallaher, M Strobl, J West, R Gatenby, J Zhang, M Robertson-Tessi, ... Cancer Research, CAN-22-2558, 2023	12*	2023
Feasibility of an Evolutionary Tumor Board for Generating Novel Personalized Therapeutic Strategies M Robertson-Tessi, JS Brown, M Poole, M Johnson, A Marusyk, ... medRxiv, 2023.01. 18.23284628, 2023	12	2023
Combining radiomics and mathematical modeling to elucidate mechanisms of resistance to immune checkpoint blockade in non-small cell lung cancer D Saeed-Vafa, R Bravo, JA Dean, A El-Kenawi, N Mon Père, M Strobl, ... BioRxiv, 190561, 2017	12	2017
Antifragile therapy J West, B Desai, M Strobl, L Pierik, R Vander Velde, C Armagost, R Miles, ... bioRxiv, 2020.10. 08.331678, 2021	11	2021
Adaptive therapy for ovarian cancer: An integrated approach to PARP inhibitor scheduling M Strobl, A Martin, J West, J Gallaher, M Robertson-Tessi, R Gatenby, ... bioRxiv, 2023.03. 22.533721, 2023	8	2023
To modulate or to skip: De-escalating PARP inhibitor maintenance therapy in ovarian cancer using adaptive therapy MAR Strobl, AL Martin, J West, J Gallaher, M Robertson-Tessi, R Gatenby, ... Cell Systems 15 (6), 510-525. e6, 2024	5	2024
Harnessing patient-specific response dynamics to optimize evolutionary therapies for metastatic clear cell renal cell carcinoma-Learning to adapt IC Sorribes, A Basu, R Brady, PM Enriquez-Navas, X Feng, JN Kather, ... bioRxiv, 563130, 2019	3	2019
The balance between intrinsic and ecological fitness defines new regimes in eco-evolutionary population dynamics RJ Barker-Clarke, JM Gray, MAR Strobl, DS Tadele, J Maltas, ... bioRxiv, 2023.03. 15.532871, 2024	2	2024
The balance between intrinsic and ecological fitness defines new regimes in eco-evolutionary population dynamics RJ Barker-Clarke, JM Gray, MAR Strobl, J Maltas, DS Tadele, ... bioRxiv, 2023.03. 15.532871, 2023	2*	2023
Learning to Adapt-Deep Reinforcement Learning in Treatment-Resistant Prostate Cancer K Gallagher, M Strobl, R Gatenby, P Maini, A Anderson bioRxiv, 2023.04. 28.538766, 2023	1	2023

Sistema negali atlikti operacijos. Bandykite vėliau dar kartą.

Straipsniai 1–20

Šaltinių per metus

Dubliuoti šaltiniai

Sujungti šaltiniai

Pridėti bendraautoriusBendraautoriai

Stebėti

Cituota

Bendraautoriai